Smiths Medical Settles

Smiths Group PLC
04 July 2005

                  Smiths Medical settles Cozmo Pump litigation



Smiths Group announces that Smiths Medical has entered into a cross-licensing
agreement with Medtronic MiniMed Inc.  The agreement terminates all pending
litigation between the companies relating to the Deltec Cozmo (R) insulin pump,
and confirms that no changes are required to the design of the pump, which is
one of a range of innovative products driving the growth of Smiths Medical.



Under the terms of the agreement Smiths will make an initial payment to
Medtronic and will pay a royalty on future sales of the current model.



The costs of the settlement will be treated as an exceptional charge in Smiths
Group's 2005 Accounts. Subject to audit, this charge is expected to be no more
than £15 million.  The impact of this settlement on the future profits of Smiths
Medical is unlikely to be material.





                                      -o-


Media:                                         Investors:
Chris Fox                                      Russell Plumley
[phone]                           [phone]
[e-mail]                     [e-mail]






                      This information is provided by RNS
            The company news service from the London Stock Exchange